ANALISIS RASIONALITAS OBAT DIABETES MELITUS TIPE II DI UPT PUSKESMAS SAKETI PERIODE JULI-DESEMBER 2023

Santi Endrawati Santi; Sariyati Maimunah; Andi Cahyadi

doi:10.36805/jbf.v5i2.1374

Santi Endrawati Santi Universitas Mathla'ul Anwar, Pandeglang Banten
Sariyati Maimunah Universitas Mathla’ul Anwar, Pandeglang, Banten
Andi Cahyadi Universitas Mathla’ul Anwar, Pandeglang, Banten

DOI: https://doi.org/10.36805/jbf.v5i2.1374

Keywords: Type II Diabetes Mellitus, Rationality, Saketi Pandeglang Health Center

Abstract

Diabetes Mellitus (DM) is a group of metabolic diseases characterized by chronic hyperglycemia, the treatment process must be carried out rationally, including correct diagnosis, correct patient, correct drug, correct dose, correct indication and correct time interval. This study aims to determine the rationality of the use of antidiabetic drugs at the Saketi Health Center UPT in the period July-December 2023. Retrospective data collection based on medical records using the Total sampling method was carried out on 138 samples that had met the inclusion and exclusion criteria. Data analysis using univariate analysis using the Microsoft Office Excel 2010 program, data was analyzed using the 2021 Perkeni literature and the Indonesian Ministry of Health 2019 for the rationality of 138 Diabetes Mellitus (DM) patients. Patient characteristics in the form of gender, there is a percentage of women 99 (72%) and men 39 (28%), Diabetes Mellitus (DM) which often occurs in the age range of 46-65 years with 110 cases (80%) The percentage of rationality of the use of diabetes mellitus drugs in patients with the right diagnosis is 138 patients 100%, right patients 138 100%, right drug selection 26 (19%) patients, wrong drug selection 112 (81%), right indication 138 patients 100%, right dose patients 138 100% and interval time of administration 138 patients.

References

Abdulkadir Widy Susanti. (2023). Potensi Interaksi Obat Antidiabetes Melitus Tipe-2 dengan Obat Antihipertensi. Journal Syifa Sciences and Clinical Research. 5 (2): 245-252.

American Diabetes Association. 2022. Standards of Medical Care in Diabetes 2022. The Journal of Clinical and Applied.

Athifah, dkk (2024). Studi Rasionalitas Penggunaan Obat Antidibetes Pada Penyakit Diabetes Melitus Tipe 2 Yang Mengalami Komplikasi Nefropati Tahun 2024, 2[1] (15), 156-168.

Hasanah Lutfianada, dkk (2022) Hubungan Kualitas Hidup Pasien Diabetes Melitus Tipe 2 Dengan Kepatuhan Minum Obat Di Rsud Ulin Banjarmasin. Journal of Current Pharmaceutical Science, Vol 6 : (1).

International Diabetes Federation. 2019.

Kemenkes. (2020). Diabetes Melitus Pusat Data dan Informasi Kementerian Kesehatan RI. Infodatin 2020.

Kuna M Rasyid, dkk. (2022). Analisis Penggunaan Obat Pada Pasien Diabetes Melitus di Puskesmas Gogamoman Tahun 2022. Jurnal Cakrawala Ilmiah Vol.2, No.4.

Luo, et al (2020). Metformin Treatment was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis. The American Journal of Tropical Medicine adnd Hygiene. 103(1), 69–72.

Madelina W., Untari, E.K., Nancy, E. (2018). Efek Perseptif Penggunaan Kombinasi Antidiabetes Oral-Insulin Pada Pasien Diabetes Melitus Tipe 2 Di Kota Pontianak Dan Sekitarnya. Jurnal Farmasi Klinik Indonesia.

Perkeni. (2011). Konsensus DM Tipe 2 Indonesia Tahun 2011. In Perkeni.

Perkeni. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Global Initiative for Asthma: 46.

Profil Puskesmas Saketi, 2023

Setyoningsih, H, dkk (2023). Pengaruh Rasionalitas Terapi Kombinasi Oral Dengan Insulin Terhadap Kontrol Glukosa Darah Pasien Diabetes Melitus Tipe 2 di Rumah Sakit Mitra Bangsa Pati. Cendekia Journal of Pharmacy Vol 7, No 1.

Suriana, dkk (2021). Asidosis Laktat Pada Penggunaan Metformin. Jurnal Ilmiah Ecosystem. 21(1).

Zulkarnain. (2021). Penguatan Ketahanan Keluarga di Tengah Pandemi Rekam Jejak Kuliah Kerja Nyata IAIN Takengon Tahun 2021. Al Musanna, Ed.; Vol. 1.